<DOC>
	<DOCNO>NCT00330200</DOCNO>
	<brief_summary>The aim study examine effect ISIS 113715 monotherapy insulin sensitivity , glucose lipid metabolism energy expenditure subject type 2 diabetes mellitus .</brief_summary>
	<brief_title>Effects ISIS 113715 Insulin Sensitivity , Glucose , Lipid Metabolism Energy Expenditure Type 2 Diabetics</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Male female ( post menopausal and/or surgically sterile ) Aged 18 70 year Treatment na√Øve subject fast blood glucose level 150220 mg/dL , hematocrit &gt; /= 35 % HbA1c level &gt; /= 7 % &lt; /= 10.0 % Subjects antidiabetic therapy fast blood glucose level 100200 mg/dL , hematocrit &gt; /= 35 % , HbA1c level &gt; /= 6.5 % &lt; /= 9.0 % Greater 3 severe hypoglycemic episode within six month screen Pregnant , breastfeeding , intend become pregnant Clinical sign symptom liver disease , acute chronic hepatitis , ALT great 1.5 time upper limit normal History hepatitis B surface antigen , hepatitis C antibody , HIV Complications diabetes ( e.g. , neuropathy , nephropathy , retinopathy ) Clinically significant currently active disease Clinically significant abnormality medical history , physical examination , laboratory examination</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2008</verification_date>
	<keyword>Fasting plasma glucose</keyword>
	<keyword>HbA1c</keyword>
	<keyword>Metabolism</keyword>
</DOC>